Drugs / Trivalent chromium
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05545020 Comparator | Dec 2022 → Jan 2024 | rheumatoid arthritis | Alexandria University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trivalent chromium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05545020 ↗ |
| Known as | Cr III | “Trivalent chromium (Cr III) is a natural element with anti-inflammatory properties.” PMID 39030450 ↗ Jul 2024 |